Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul‐de‐sac?
Year: 2007
Type: review
Abstract: UNLABELLED: Negative symptoms of schizophrenia are debilitating and they contribute to poor outcome in schizophrenia. Initial enthusiasm that second-generation antipsychotics would prove to be powerful agents to improve negative symptoms has given way to relative pessimism that the effects of current pharmacological treatments are at best modest. METHOD: A review of the current 'state-of-play' of pharmacological treatments for negative symptoms in schizophrenia. RESULTS: Treatment results to date have been largely disappointing. The evidence for efficacy of second-generation antipsychotics is reviewed. CONCLUSION: The measurement and treatment trials methodology for the evaluation of negative symptoms need additional refinement before therapeutic optimism that better treatments for negative symptoms can be realized.
Source: Acta Psychiatrica Scandinavica
Authors: P. F. Buckley, S. M. Stahl
Institutions: Augusta University, University of California San Diego
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2045658109
